We are live on ! Find out more
PAP

Persistent Asset Partners Portfolio holdings

AUM $268M
1-Year Est. Return 158.98%
This Fund
S&P 500
This Quarter Est. Return
+35.4%
1 Year Est. Return
+158.98%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$268M
AUM Growth
+$45.6M
Cap. Flow
+$18.2M
Cap. Flow %
6.78%
Top 10 Hldgs %
33.7%
Holding
508
New
146
Increased
78
Reduced
73
Closed
186

Sector Composition

1 Technology 44.62%
2 Healthcare 29.67%
3 Financials 9.04%
4 Consumer Discretionary 3.92%
5 Energy 3.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TERN
26
DELISTED
Terns Pharmaceuticals
TERN
$2.42M 0.9%
45,953
-67,602
-60% -$2.78M
SMTC icon
27
Semtech
SMTC
$11.6B
$2.41M 0.9%
+31,355
New +$2.58M
QRVO icon
28
Qorvo
QRVO
$7.54B
$2.33M 0.87%
+30,096
New +$2.44M
BMRN icon
29
BioMarin Pharmaceuticals
BMRN
$11.5B
$2.12M 0.79%
37,472
-1,663
-4% -$97K
AX icon
30
Axos Financial
AX
$5.66B
$1.98M 0.74%
23,326
+20,988
+898% +$1.91M
KOD icon
31
Kodiak Sciences
KOD
$2.67B
$1.96M 0.73%
+51,336
New +$1.33M
APGE icon
32
CALL
Apogee Therapeutics
APGE
$10.1B
$1.93M 0.72%
566
NBIS
33
Nebius Group N.V.
NBIS
$45.1B
$1.88M 0.7%
18,166
-11,834
-39% -$1.18M
CCB icon
34
Coastal Financial
CCB
$1.2B
$1.88M 0.7%
24,673
+9,237
+60% +$835K
INCY icon
35
Incyte
INCY
$23.4B
$1.86M 0.69%
+19,782
New +$1.97M
EGO icon
36
Eldorado Gold
EGO
$7.28B
$1.79M 0.67%
52,246
+1,911
+4% +$77.9K
BBIO icon
37
BridgeBio Pharma
BBIO
$15.9B
$1.77M 0.66%
23,810
+5,114
+27% +$371K
TGTX icon
38
TG Therapeutics
TGTX
$8.4B
$1.76M 0.66%
53,080
+19,868
+60% +$592K
LLY icon
39
Eli Lilly
LLY
$1.05T
$1.75M 0.65%
1,906
+1,373
+258% +$1.39M
EQX icon
40
Equinox Gold
EQX
$6.81B
$1.73M 0.65%
119,767
+5,366
+5% +$82K
CVBF icon
41
CVB Financial
CVBF
$4.03B
$1.65M 0.61%
85,025
+56,962
+203% +$1.12M
SAIL
42
SailPoint Inc
SAIL
$8.89B
$1.58M 0.59%
119,161
+50,000
+72% +$780K
VKTX icon
43
CALL
Viking Therapeutics
VKTX
$4.3B
$1.52M 0.57%
1,672
-167
-9% -$5.37K
PDD icon
44
Pinduoduo
PDD
$120B
$1.51M 0.56%
14,732
-1,691
-10% -$178K
TGB
45
Trekor Metals
TGB
$2.48B
$1.48M 0.55%
229,605
-28,724
-11% -$209K
IMCR icon
46
Immunocore
IMCR
$1.78B
$1.48M 0.55%
48,962
+21,030
+75% +$680K
EXE
47
Expand Energy Corp
EXE
$21.1B
$1.46M 0.54%
13,077
+4,669
+56% +$499K
MRVL icon
48
Marvell Technology
MRVL
$169B
$1.45M 0.54%
+14,682
New +$1.23M
CMBT
49
CMB.TECH NV
CMBT
$4.34B
$1.39M 0.52%
111,110
+56,110
+102% +$704K
ABBV icon
50
AbbVie
ABBV
$450B
$1.33M 0.5%
+6,126
New +$1.36M

Similar funds

Persistent Asset Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Persistent Asset Partners held 508 positions worth $268M, up 20% from $223M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Persistent Asset Partners deployed $18.2M of net new capital in Q1 2026, opening 146 new positions and adding to 78 existing holdings. Its largest new stake was Tower Semiconductor: 67,608 shares worth $11.9M.

By sector, the portfolio is most concentrated in Technology at 45% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Terns Pharmaceuticals, an estimated $2.78M trimmed.

  • Persistent Asset Partners's largest Q1 2026 buy was Tower Semiconductor: 67,608 shares worth $11.9M.
  • Persistent Asset Partners added most to Lumentum in Q1 2026, an estimated $8.24M increase.
  • Persistent Asset Partners's biggest Q1 2026 reduction was Terns Pharmaceuticals, cutting an estimated $2.78M.
  • Persistent Asset Partners fully exited Centene in Q1 2026, selling an estimated $9.07M.
  • Persistent Asset Partners's ten largest holdings make up 34% of its $268M portfolio in Q1 2026.
  • Persistent Asset Partners opened 146 new positions and closed 186 in Q1 2026.
  • Persistent Asset Partners's portfolio value rose 20% quarter-over-quarter to $268M.

Based on Persistent Asset Partners's 13F filing for Q1 2026, filed 12 May 2026.